Adriene Y. Ishimoto

Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients

T. Kohlsdorf, A. Fabro, F. Cunha, 2020, The Journal of experimental medicine.

Inflammasome activation in COVID-19 patients

T. Kohlsdorf, A. Fabro, F. Cunha, 2020, medRxiv.

Efferocytosis of SARS-CoV-2-infected dying cells impairs macrophage anti-inflammatory functions and clearance of apoptotic cells

H. Nakaya, A. Fabro, J. Alves-Filho, 2022, eLife.

Identification of immunomodulatory drugs that inhibit multiple inflammasomes and impair SARS-CoV-2 infection

A. Fabro, P. Louzada-Junior, Tamara S. Rodrigues, 2022, Science advances.

Efferocytosis of SARS-CoV-2-infected dying cells impairs macrophage anti-inflammatory programming and continual clearance of apoptotic cells

A. Fabro, F. Cunha, J. Alves-Filho, 2021, medRxiv.

Gasdermin-D activation promotes NLRP3 activation and host resistance to Leishmania infection

D. Zamboni, S. Oliveira, S. Batah, 2023, Nature Communications.